![Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | British Journal of Cancer Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2011.328/MediaObjects/41416_2011_Article_BFbjc2011328_Fig1_HTML.jpg)
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | British Journal of Cancer
![Frontiers | Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers Frontiers | Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers](https://www.frontiersin.org/files/Articles/970918/fonc-12-970918-HTML/image_m/fonc-12-970918-g001.jpg)
Frontiers | Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers
![Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network](https://www.spandidos-publications.com/article_images/or/40/5/OR-40-05-2659-g06.jpg)
Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network
![Changes in ovarian cancer survival during the 20 years before the era of targeted therapy | BMC Cancer | Full Text Changes in ovarian cancer survival during the 20 years before the era of targeted therapy | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4498-z/MediaObjects/12885_2018_4498_Fig1_HTML.png)
Changes in ovarian cancer survival during the 20 years before the era of targeted therapy | BMC Cancer | Full Text
![Ovarian Cancer Patient | Sara's Story: Getting Through Surgery, Chemo, PARP Inhibitor (Video 2/3) - YouTube Ovarian Cancer Patient | Sara's Story: Getting Through Surgery, Chemo, PARP Inhibitor (Video 2/3) - YouTube](https://i.ytimg.com/vi/pFpYhx8AOnc/maxresdefault.jpg)